FindMyKOL

Michael Einstein, MD

Basic profile

Hartford Hospital

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionHartford, CT · NortheastSpecialtyGastroenterologyFocusGastroenterology
Active KOLFindMyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Michael Einstein is a Gastroenterology physician affiliated with Hartford Hospital. OpenAlex indexes 50 publications with 453 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
50publications

Publications indexed by OpenAlex. Counts exclude supporting files.

453citations

Citations across these publications.

10h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
40companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

40 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Gilead Sciences, Inc.
    Program year202552 payments
    $15,760
  • Ipsen Biopharmaceuticals, Inc
    Program year20253 payments
    $7,350
  • Mirum Pharmaceuticals, Inc.
    Program year20254 payments
    $3,317
All 82 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    37.4%
    Proton pump inhibitor12.2%
    Pantoprazole Sodium79%Omeprazole21%
    Part D≥40 patients
    Bile Acid6.6%
    Ursodiol100%
    Part D≥27 patients

    + 7 more classes in this area

  • Cardiovascular

    29.8%
    Beta blocker9.7%
    Propranolol Hcl41%Carvedilol34%Nadolol25%
    Part D≥22 patients
    Loop diuretic7.6%
    Furosemide100%
    Part D≥31 patients

    + 4 more classes in this area

  • Cancer & immunology

    16.9%
    Calcineurin inhibitor14.2%
    Tacrolimus92%Envarsus Xr8%
    Part D<11 patients
    Purine Antimetabolite2.7%
    Azathioprine100%
    Part D<11 patients
Where care is delivered (Part B)82.5% facility · 17.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”